Archive for the ‘Polaris Group’ Category

Polaris Group

February 5th, 2014 | Posted in 2014, Polaris Group

Polaris Group – Drug to help treat pancreatic cancer:  Polaris Group recently announced that ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, acts as a radiosensitizer of pancreatic cancer both in tissue culture and in mice with human pancreatic cancer. Clinical trials are being conducted.